top of page


banner v right blue.png
Oesophagogastric Cancer.png

Oesophagogastric Summits

Improving outcomes for people with oesophagogastric (upper GI) cancer is particularly challenging. Chances for early detection are slim and many present at a late stage of disease. Eighty members of oesophagogastric cancer multidisciplinary teams across Victoria gathered together on the August 26, 2016 to review variations in care and identify opportunities to improve the outcomes and experiences of care.

The scene was set by three senior Upper-GI surgeons; Professor Robert Thomas, Chief Cancer Advisor to the Department of Health and Human Services; Mr Paul Cashin of Monash Health and Mr Ahmad Aly of Austin Health.

Professor Thomas opened the event highlighting the importance of the multidisciplinary team approach to cancer care and introducing the optimal care pathway for people with oesophagogastric cancer as an important document that sets a common understanding of what care to expect at different points in the cancer journey. Mr Cashin welcomed the participants and set the task of identifying opportunities for improving outcomes and the organisation of care for Victorians diagnosed with oesophagogastric cancer.

Oesophagogastric 2016 Summit Clinical Working Party

  • Mr Ahmad Aly (Chair)

  • Dr Peter Briggs

  • Mr Paul Burton

  • Mr Paul Cashin

  • Mr Gary Crosthwaite

  • Mr David Deutscher

  • Mr Cuong Duong

  • Dr Samuel Harris

  • Mr Matthew Leong

  • Prof Trevor Leong

  • Mr Kiat Lim

  • A/Prof Sue-Anne McLachlan

  • A/Prof Peter Nottle

  • Mr John Spillane

  • Dr Niall Tebbutt

  • Dr Zee Wan Wong

Oesophagogastric Cancer 2016 Summit Material

Oesophagogastric Summit Material 2016
Oesophagogastric 2016 Summit Data Presentation

Mr Ahmed Aly

Data Variations

  • There are lower rates of multidisciplinary meeting discussion for regional / rural patients.

  • Documentation of staging at multidisciplinary meeting sits at 53% for the state.

  • 63% of patients with oesophageal cancer had an oesophagectomy in their ICS of residence and 75% had first chemotherapy in their ICS of residence.

  • 73% of patients with gastric cancer had a gastrectomy in their ICS of residence and 81% had first chemotherapy in their ICS of  residence.

bottom of page